|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_ocn892069065 |
| 003 |
OCoLC |
| 005 |
20231120111803.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
141003s1975 nyua ob 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d N$T
|d EBLCP
|d DEBSZ
|d YDXCP
|d OCLCQ
|d MERUC
|d OCLCQ
|d INARC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 897643714
|a 948744185
|
| 020 |
|
|
|a 9781483269566
|q (electronic bk.)
|
| 020 |
|
|
|a 1483269566
|q (electronic bk.)
|
| 020 |
|
|
|z 0126355037
|
| 020 |
|
|
|z 9780126355031
|
| 035 |
|
|
|a (OCoLC)892069065
|z (OCoLC)897643714
|z (OCoLC)948744185
|
| 050 |
|
4 |
|a QR186.5
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.079
|2 22
|
| 245 |
0 |
4 |
|a The antigens /
|c edited by Michael Sela.
|n volume 3.
|
| 264 |
|
1 |
|a New York :
|b Academic Press,
|c 1975.
|
| 300 |
|
|
|a 1 online resource (xvi, 624 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover; The Antigens; Copyright Page; Table of Contents; List of Contributors; Preface; Contents of Other Volumes; CHAPTER1. Microbial Polysaccharides; I. Introduction; II. Chemistry of Microbial Polysaccharide Antigens; III. Immunochemistry of Microbial Polysaccharide Antigens; IV. Immunobiology of Microbial Polysaccharide Antigens; V. Summary and Conclusions; Acknowledgments; References; CHAPTER2. Antigenic Determinants and Antibody Combining Sites; I. Introduction; II. The Structural Specificity of Hapten-Antibody Interactions; III. Antigenic Determinants.
|
| 505 |
8 |
|
|a IV. The Antibody Combining SiteV. Immunogenic Determinants; VI. Concluding Remarks; Acknowledgment; References; CHAPTER3. Lymphocytic Receptors for Antigens; I. Introduction; II. Historical; III. Two Classes of Lymphocytes; IV. The Lymphocyte Plasma Membrane; V. Relevant Properties of Immunoglobulins; VI. Immunoglobulins on the Lymphocyte Plasma Membrane; VII. The Binding of Antigen to Lymphocytes; VIII. Specificity and Immunocompetence of ABC; IX. Receptors on Lymphocytes for Antigens; X. Antigens, The Antigen-Receptor Complex, and Mitogens; XI. Inside the B Cell; Acknowledgments; References.
|
| 505 |
8 |
|
|a CHAPTER4. Allergens and the Genetics of AllergyI. Introduction; II. Historical Development (1872-about 1960; III. Nomenclature; IV. Modern Allergen Research; V. Nature of Allergenic Sensitization and Stimulation; VI. Genetics of Allergy; VII. Practical Considerations; VIII. Concluding Remarks; Acknowledgments; References; CHAPTER5. A Biologic and Chemical Profile of Histocompatibility Antigens; I. Introduction; II. History; III. Genetics; IV. Serologie Detection of H Antigens; V. Cell Surface Expression of H Antigens; VI. Cross-Reactivity of H Antigens.
|
| 505 |
8 |
|
|a VII. Extraction, Purification, and Biologie Activityof Soluble H AntigensVIII. Chemical and Molecular Nature of HL-A Antigens; IX. Perspectives; Acknowledgments; References; CHAPTER6. Antigens of the Mycoplasmatales and Chlamydiae; I. Introduction; II. Classification and Nomenclature; III. Biology; IV. Phylogenetic Relationships; V. Antigenic Analysis of Mycoplasmata; VI. Antigenic Analysis of Chlamydiae; VII. Growth Inhibition and Mycoplasmacidal Activity of Serum; VIII. Antigenic Structure; References; CHAPTER7. Virus Infections and the Immune Responses They Elicit; I. Introduction.
|
| 505 |
8 |
|
|a II. Viral AntigensIII. Humoral Responses; IV. Secretory Antibody Responses; V. Thymus Dependence of Viral Antigens; VI. B Lymphocyte Memory and Original Antigenic Sin -- VII. Neutralization; VIII. Capacity of Macrophages to Support Virus Replication; IX. Ontogeny of Macrophage Resistance to Viral Infections; X. Surface Changes of Virus-Infected Cells; XI. Evidence for Cell-Mediated Immunity to Viral Antigens; XII. Persistence of Immunity to Viruses; XIII. Tolerance to Viral Antigens; XIV. Cooperative Effects of Viral Antigens on Immunogenicity.
|
| 650 |
|
0 |
|a Antigens.
|
| 650 |
|
0 |
|a Immunoglobulins.
|
| 650 |
|
2 |
|a Antigens
|0 (DNLM)D000941
|
| 650 |
|
6 |
|a Antig�enes.
|0 (CaQQLa)201-0001668
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Antigens
|2 fast
|0 (OCoLC)fst00810523
|
| 650 |
|
7 |
|a Immunoglobulins
|2 fast
|0 (OCoLC)fst00967961
|
| 700 |
1 |
|
|a Sela, M.
|
| 776 |
0 |
8 |
|i Print version:
|t Antigens / volume 3
|z 0126355037
|w (OCoLC)223612593
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780126355031
|z Texto completo
|
